Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexamethasone for Post-Operative Sore Throat with Ambu AuraGain
NCT04771026Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in postoperative sore throat (POST), cough and hoarseness (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoint: Incidence of Post-Operative Sore Throat at 24 hours. Started Dec 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative sore throat (POST)coughhoarseness
Beyond the preview
Go deeper on NCT04771026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771026.